Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients

por Shaker, Mohamed K, Abdel Fattah, Hanzada I, Sabbour, Ghada S, Montasser, Iman F, Abdelhakam, Sara M, El Hadidy, Eman, Yousry, Rehab, El Dorry, Ahmed K
Publicado 2017

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

por Azim, Hamdy A, Omar, Ashraf, Atef, Hesham, Zawahry, Heba, Shaker, Mohamed K, Abdelmaksoud, AH Kamel, EzzElarab, Mohamed, Abdel-Rahman, Omar, Ismail, Mohamed, Kassem, Loay, Waked, Imam
Publicado 2018